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Abstract 
The Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive multiple congenital malformation 
syndrome caused by dehydrocholesterol reductase deficiency. The diagnosis is confirmed by high 7- 
and secondarily 8-dehydrocholesterol levels in plasma and tissues and/or by detection of biallelic 
mutations  in  the  DHCR7 gene.  The  phenotypic  spectrum of  SLOS is  broad,  ranging  from a  mild 
phenotype  combining  subtle  physical  anomalies  with  behavioral  and  learning  problems,  to  a 
perinatally lethal multiple malformations syndrome. The fetal phenotype of SLOS has been poorly 
described in the literature. We report a series of 10 fetuses with molecularly proven SLOS.  Even in 
young fetuses, the facial dysmorphism appears characteristic. Genital abnormalities are rare in 46, XX 
subjects.  Gonadal  differentiation  appears  histologically  normal  and  in  agreement  with  the 
chromosomal  sex,  contrary  to  what  has  been  previously  stated.  We  observed  some  previously  
unreported anomalies:  ulnar hypoplasia, vertebral segmentation anomalies,  congenital pulmonary 
adenomatoid malformation,  fused lungs,  laparoschisis,  holomyelia  and hypothalamic hamartoma. 
This latter malformation proves that SLOS phenotypically overlaps with Pallister-Hall syndrome which 
remains clinically a major differential diagnosis of SLOS.
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Introduction
Smith-Lemli-Opitz  syndrome  (SLOS,  MIM270400)  is  an  autosomal  recessive  multiple 
congenital malformation syndrome with growth failure and mental retardation, first delineated in  
1964. SLOS results from reduced activity of 7-dehydrocholesterol reductase, the final enzyme of the 
cholesterol  biosynthesis  pathway  {Porter,  2011  #28}  that  converts  7-dehydrocholesterol  to 
cholesterol.  SLOS  diagnosis  can  be  confirmed  by  demonstrating,  by  gas  chromatography-mass  
spectrometry (GC-MS), elevated precursor sterols, mainly 7- and 8-dehydrocholesterol in plasma and 
tissues, sometimes with low plasma cholesterol levels. In 1998, mutations in the DHCR7 gene were 
shown to cause SLOS .  Over 130 different mutations  have now been identified in SLOS patients 
(detection rate 96%), among which the common, recurrent mutation IVS8-1G>C and two frequent 
mutations in Poland (W151X and V326L) . The incidence of SLOS has been estimated to be 1/20 000-
1/70 000  but is strikingly different among various ethnic groups. The frequency of heterozygote is 
estimated as 3 to 4% in the Caucasian populations, a value that seems incompatible with the low  
reported incidence .
The phenotypic spectrum of SLOS is very broad, ranging from mild minor physical anomalies  
with  behavioral  and  learning  problems  to  a  prenatally  or  perinatally  lethal  multiple  congenital  
anomaly (MCA) syndrome. Post-natal clinical findings in molecularly proven SLOS and their frequency 
have been reported by Kelley et al.  and by Goldenberg et al. , but the fetal phenotype has rarely be 
addressed. Goldenberg  et al.  briefly described 12 fetuses among a series of 45 SLOS .  The same 
authors reviewed ultrasound findings in a series of 30 biochemically confirmed SLO cases  : nuchal  
edema (during the first  trimester of  pregnancy),  renal,  cardiac or cerebral  anomalies,  ambiguous 
genitalia  or  a  46,XY  karyotype  in  a  phenotypically  female  fetus  and  polydactyly  were  the  most  
common findings. Only two other biochemically confirmed fetal cases have been reported .
Prenatal diagnosis of SLOS can be essentially done either by sterols profiling in amniotic fluid  
or  chorionic  villi,  or  by  DHCR7 molecular  analysis  .  Moreover  maternal  urine  or  serum  steroid 
measurements by GC-MS (pregnanetriol, 7-dehydropregnanetriol, 8-dehydropregnanetriol,  oestriol 
and  8-dehydroesteriol)  should  be  a  reliable  non-invasive  technique  between  14  and  22  weeks’  
gestation . Antenatal diagnosis of SLOS is often made following familial history or ultrasound findings  
(mainly growth retardation with genital abnormalities). A better knowledge of the fetal phenotype of 
SLOS could help the practitioners of fetal medicine units to diagnose more accurately SLOS during 
pregnancy. 
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We  report  here  the  phenotype  of  10  fetal  SLOS  confirmed  by  biochemical  assays  and 
molecular studies.
Materials and Methods
The series was build retrospectively through a conjoint effort of the members of the French fetal  
pathology society  (SOFFOET).  We collected data  on 10 fetuses  with  Smith-Lemli-Opitz  syndrome 
(born between 1999 and 2010). Termination of pregnancy (TOP)  was performed in accordance with 
the French legislation and was followed by fetopathologic examination. The gestational age at which 
TOP was performed varied from 16 weeks of gestation (GW) to 34 GW. There was 5 46,XX and 5 
46,XY fetuses. None of them was born to consanguineous parents and there was no positive family 
history of SLOS.
In accordance with the French bioethic laws, written signed consent was obtained from (at least) the 
mother  for  pathological  examination  and  for  genetic  investigations.  Standard  fetal  examination 
included photographs, evaluation of the fetal biometrics, X ray survey, external examination, autopsy 
and examination of placenta. All viscera, including the brain, were dissected, weighed and  stained 
with  hematoxylin-eosin  (H&E)  for  histologic analysis.  Fetal  and/or  placental  tissue samples  were 
frozen for biochemical analysis and DNA extraction.
Diagnosis of SLOS were suspected on fetal phenotype at prenatal ultrasound scan (USS) for cases 2 
and 7 or at fetopathologic examination, and no other diagnostics tests has been performed, except 
GLI3 sequencing  in  case  6  (see  below). Elevated  7-dehydrocholesterol  and  8-dehydrocholesterol 
were assayed in liver tissue, lung tissue or fetal blood, using GC-MS. Molecular analysis of the DHCR7 
gene  was  performed  using  standard  molecular  procedures.  Segregation  of  the  variants  was 
confirmed by studying parental DNA.
Results
Prenatally detected anomalies (Table 1)
At  prenatal  USS,  four  fetuses  (on  eight)  showed  increased  nuchal  translucency.  The  main  USS  
anomalies were intrauterine growth retardation (IUGR) with oligo- or anhydramnios in seven cases, 
congenital heart defects, limb defects (mainly postaxial polydactyly), cerebral and renal anomalies. 
One fetus had only IUGR associated with pulmonary valvular dysplasia.
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Fetal pathology (Tables 1 and 2) 
Seven fetuses  showed IUGR and two were between the 10 th and the 25th centile.  Most  showed 
micromelia with short long bones. Facial dysmorphism was noted in all fetuses, mainly short nose  
with anteverted nares (Fig. 1). Cleft palate or bifid uvula was seen in 4 fetuses. All fetuses had some 
limb defects: syndactyly of toes II-III, postaxial polydactyly of hands and feet, short and proximally  
placed  thumbs  and  deep  distal  palmar  crease  between  the  second  and  third  fingers,  giving 
sometimes a “split hand like” appearance (Fig. 2). All female fetuses had normal external genitalia,  
and all  male fetuses  had ambiguous genitalia  (Fig.  3).  One fetus (case  5) had bicornuate uterus  
bicollis (Fig. 4A). Microscopic examination of the gonads disclosed normal ovaries in all 46,XX fetuses  
and testes  in  all  46,XY  fetuses,  without  histologic  evidence of  gonadal  dysgenesis.  Most  fetuses  
(8/10) had abnormal lung segmentation and renal hypoplasia or agenesis (8/10). One fetus only had 
a  normal  heart.  One  fetus  had  anomalous  pulmonary  venous  return.  3  fetuses  had  common 
mesentery. Two fetuses had polysplenia and two had enlarged pancreatic tail. Radiologic anomalies 
included  shortened  long  bones  and  brachymesophanlangy  of  fingers  II  (Fig.5).  Four  fetuses  had 
cerebral  biometries  on  the  5th centile,  and  five  had  true  microcephaly.  Holoprosencephaly  was 
present  in  one  case.  Anomalies  not  reported  before  in  SLOS  included  congenital  pulmonary 
adenomatoid  malformation,  fused  lungs,  laparoschisis  (Fig  4A),  hypothalamic  hamartoma  and 
holomyelia (Fig. 4B), vertebral segmentation defects and ulnar hypoplasia (Fig. 5).
Metabolic and genetic screening
The clinical diagnosis of SLO syndrome was confirmed by high levels of 7-dehydrocholesterol and 8-
dehydrocholesterol  in liver,  lung or fetal  blood in all  cases but case 8 (Table 3).  For case 7,  the 
diagnosis was confirmed by prenatal sterol measurement performed on amniotic fluid (cholesterol  
0.03  g/l,  7-DHC  0.023g/l  and  8-DHC  0.017  g/l). Molecular  analysis  of  the  DHCR7 gene  showed 
compound heterozygote mutations in 7 cases and homozygote mutations in 3 cases (Table 3).  In 
fetus 5, 3 mutations were identified in the DHCR7 gene, two of which in exon 4 inherited from the 
father (c.208G>T and c.149C>T) and the third mutation inherited from the mother. Because of the 
existence of a hypothalamic hamartoma in case 6, a coincident mutation of  GLI3 was excluded by 
direct sequencing.
Discussion
Several  differences  exist  between our  prenatal  series  and  the  postnatal  ones  :  renal  anomalies  
(mainly hypoplasia)  are reported in all  cases of this  series,  versus 40%; pulmonary segmentation 
defects are present in 9/10 fetuses of our study, versus 17%-45%; incidence of intestinal malrotation  
was  6% in  a  previous  series  ,  but  affected  60% of  the  fetuses  of  this  study  ;  and  finally  brain  
6
malformations  are  also  more  frequent  in  our  study.  Obviously,  fetopathologists  can  describe 
anomalies which are less accessible to pediatric examination. To the contrary, some typical findings 
of SLOS, as cataracts or colonic aganglionosis, are difficult to assess histologically and can be missed 
antenatally. Incidence of others malformations, such as limb anomalies, is in agreement with the  
literature, except for absent or hypoplastic middle phalanx of the second finger that seems more  
frequent  than  previously  suspected. Lin  et  al.  reported  five  major  types  of  heart  defects: 
atrioventricular canal, atrial septal defect ostium secundum type, patent ductus arteriosus, abnormal  
pulmonary venous return (APVR) and ventricular septal  defects.  In this  series,  nine fetuses have 
cardiac defects, mostly atrioventricular canal. Facial dysmorphism is present even in midtrimester 
fetuses: bitemporal narrowing, hypertelorism, short nose with anteverted nares, microretrognathia, 
large mouth, low set and posteriorly rotated ears and short neck. In case 5, these anomalies are  
blurred out by holoprosencephaly, a malformation which has been reported previously in nine SLOS 
patients . All male fetuses have external genital anomalies ranging from bifid scrotum to apparently 
female appearance.  To the contrary,  the female fetuses of  this  series have no anomalies of  the 
external  genitalia.  Case 5 has bicornuate uterus,  a  rare but already described malformation.  We 
observed normal gonadal differentiation in all our XY fetuses, irrespective of the level of external  
ambiguity. Referring to an article published in 1974, when biochimical diagnosis of SLOS was not  
possible,  Kelley  et  al.   stated that gonads varies from normal  testes  to ovotestis  and to normal  
ovaries,  or  may  be  missing.  No publication  has  addressed  this  issue  since  the  discovery  of  the 
metabolic anomaly of SLOS, and gonadal differentiation was not described in two recent fetal cases .  
We suspect that the 1974 paper was based on a syndromologically heterogeneous collection. Indeed,  
our observation is not surprising, considering the fact that gonadal differentiation is not influenced 
by gonadal steroids. Our series confirms the retrospective data of Goldenberg on prenatal USS signs .  
All fetuses but one have IUGR of variable severity. Microcephaly is the most common sign during the  
2nd and 3rd trimester of pregnancy. Case 9 has normal growth parameters at 16 GW, but growth 
retardation may not be present as early. For case 1, IUGR was the major antenatal sign. Non-vascular 
IUGR should prompt the sonographer to consider SLOS, especially  when karyotype is 46,XX.  Two 
fetuses in our series were diagnosed early in the second trimester (fetus 9 and 10). Our study shows 
for the first time that early fetal phenotype of SLOS is recognizable and very similar to the phenotype 
of elder children. Indeed facial dysmorphism, already present, was felt to be a good handle to elicit  
the  diagnosis  in  a  MCA fetus.  These  two cases  illustrate  the  high  interest  of  pathological  fetal  
examination  even  for  young  MCA  fetuses  who  should  therefore  not  be  terminated  by  surgical  
aspiration to allow a complete fetal examination.
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We  observed  atypical  manifestations  of  SLOS.  Many  skeletal  malformations  have  been 
reported in SLOS, as polydactyly,  metacarpal/tarsal  hypoplasia, syndactyly,  disproportionate short 
limbs, chondrodysplasia punctata, ribs anomalies, scoliosis, kyphosis or high ovoid lumbar vertebral 
bodies  .  A  single  patient  suspect  of  SLOS  was  reported  with  ectrodactyly,  radial  aplasia  and  
monodactyly  .  We now definitively  add ulnar  hypoplasia  (patient  3)  and vertebral  segmentation  
anomalies (patient 3) to this  list.  Five fetuses also have a deep distal  palmar crease with widely  
separate  the  second  and  third  fingers,  giving  a  “split  hand  like”  appearance  (Fig.  2).  Abnormal 
pulmonary  development  has  already  been  reported  in  SLOS.  We can  add  congenital  pulmonary 
adenomatoid malformation and fused lungs (Fig. 4A) to the list. The laparoschisis observed in case 4 
may be fortuitous, but could mislead the clinician. Fetus 8 (previously been reported by  Marcorelles  
and Laquerriere ) has holomyelia, which is a partial or complete fusion of both anterior horns of the  
spinal cord. Distal arthrogryposis may be the result of this developmental anomaly. The presence of a 
hypothalamic  hamartoma  in  fetus  6  makes  SLOS  overlap  with  Pallister-Hall  syndrome  (PHS, 
MIM146510),ascribed to GLI3 mutations.  Hypothalamic hamartoma, short limbs, postaxial or central 
polydactyly  (with  Y  shaped  central  metacarpal  or  tarsal)  and  dysplastic  nails,  bifid  epiglottis  or  
laryngotracheal  cleft,  imperforate  anus  and  other  visceral  malformations  (renal  abnormalities, 
genitourinary  anomalies  or  abnormal  lung  segmentation)  are  the  hallmarks  of  PHS  .  Similarities  
between both syndromes have been stressed , but hypothalamic hamartoblastoma has never been 
formally  reported  with  SLOS.  When  both  diseases  where  still  unexplained,  Donnai  et  al. even 
suggested that the Pallister-Hall syndrome and severe Smith-Lemli-Opitz syndrome may represent 
phenotypic variations of one condition . Indeed, some ancient cases may have been misdiagnosed on  
clinical ground in the past. Verloes et al.  suggested that patient 6 from the seminal report of PHS , 
who had an hamartoma, flat nose, low-set and posteriorly rotated ears, micrognathia, left postaxial  
polydactyly, bilateral 2/3 toes syndactyly, bilateral cataracts and Hirschprung disease, had SLOS and 
not PHS. Interestingly, this phenotypic overlap with PHS and the possible holoprosencephaly/midline  
defects observed in SLOS suggest a defect in SHH pathway in SLOS mutated patients. Indeed, SHH 
protein  precursor  undergoes  autocatalytic  internal  cleavage  mediated  by  covalently  attached 
cholesterol to the N-terminal signaling domain, and the potential effects of perturbed cholesterol  
biosynthesis  on  embryonic  signaling  proteins  has  already  been  discussed  in  SLOS  .  Distinction 
between these two syndromes  is  of  obvious  significance  for  genetic  counseling,  as  Pallister-Hall  
syndrome is an autosomal dominant disorder (mainly sporadic cases resulting from  de novo GLI3 
mutations), whereas SLOS is recessively inherited. We report for the first time systematic histologic 
examination of SLOS placenta. This organ has grossly normal architecture, but three fetuses show 
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placental hypotrophy. It will be of interest to better study placentas of SLOS in order to confirm and 
precise these anomalies.  
There is an apparent discordance between the  low incidence of SLOS as compared to the 
estimate carrier frequency . Jezela-Stanek  et al. established the prospective incidence of SLOS in 
Poland in order to compare it to a previous carrier frequency estimation, but doesn’t resolve this  
discrepancy  between the  predicted  and  observed  incidence  .  No  segregation  of  SLOS  has  been 
published. The “missing SLOS” may correspond to the two tails of the clinical spectrum: SLOS may 
remain undiagnosed among mildly affected individuals who do not show the key features that would  
trigger  cholesterol  analysis,  and  severe  cases  may  stay  hidden  among  early  miscarriages.  In  
accordance with this hypothesis, 4 couples suffered multiple early spontaneous abortions (2 for case  
6, 5 for case 8, 5 for case 9 and 1 for case 10). For case 1, pregnancy obtained by in vitro fertilization 
was  initially  gemellar  bichorionic  biamniotic  and  reduced  spontaneously.  For  case  6,  the  fourth  
pregnancy ended at 6 GW and the sterols analysis by GC-MS in miscarriage product (case 6’) showed  
high levels of 7- and 8-dehydrocholesterol, confirming recurrence (Table 3). Moreover, three fetuses 
had increased nuchal translucency in the first trimester of pregnancy. As Maymon et al., we could 
speculate,  that  some of  fetal  loss  associated  with  SLOS  may  be  related  to  nuchal  oedema and 
subsequent fetal hydrops, reflecting the severity of the phenotype in these families . SLOS could be 
an  unsuspected  cause  of  recurrent  early  spontaneous  abortions  without  identified  cause,  but 
systematic screening of DHCR7 In couples with recurrent miscarriages has never been carried on.
All the fetuses, who can be considered as severe (prenatally detected), were genotyped and 
found  to  be  either  homozygous  or  compound  heterozygous,  with  at  least  one  null  allele. Our 
observation confirms that severe phenotypes are mainly associated with nonsense and splice-site 
mutations (null alleles) , although strict genotype-phenotype correlations are difficult and significant  
variation is seen in severity even among individuals with similar mutations, suggesting influences of 
other factors on the phenotype. Fetus 5 with holoprosencephaly has 3 deleterious mutations, which  
could partly explain the severity of the phenotype. The efficiency of cholesterol transport from the 
mother to the fetus early in pregnancy may be one of these factors. For example, Apolipoprotein E  
protein is a major component of the cholesterol transport system in humans and studies suggest that  
the maternal  apolipoprotein  E genotype (ApoE)  was implicated in  phenotype heterogeneity,  the 
maternal apo epsilon2 genotype (APOE2 protein) being associated with a severe Smith-Lemli-Opitz  
syndrome phenotype . Another hypothesis might be modifier alleles of genes belonging to the SHH 
signaling pathway.
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In summary, we report 10 fetuses with SLOS, illustrating the broad clinical variability in the severe 
end  of  spectrum  of  this  disorder  and  question  the  potential  role  of  DHCR7 deficiency  in  early 
abortion. We illustrate the usefulness of systematic feto-placental examination in syndromes which 
are  not  universally  lethal:  several  anomalies  that  we describe  would  probably  never  have  been  
reported in  pediatric  series,  as  morphologically-oriented autopsies  are  rarely  performed in  elder 
children, and as feto-placental examination allows exhaustive description of anomalies which are not  
easily accessible by clinical inspection or ex vivo imaging.
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Tables
Table 1: Prenatally detected anomalies and external phenotypic description of the 10 fetuses with Smith-Lemli-Opitz 
syndrome
(AVC Atrioventricular Canal ; B Bilateral ; CCA Corpus Callosum Agenesis ; CLP Cleft Lip and Palate ; CH Crown-Heel lenght ; CIV Interventricular  
communication ; CRL: Crown-Rump Length ; GW: gestational weeks ; HLH Hypoplastic Left Heart ; L Left ; ND Not determined ; R Right ; SA Spontaneous  
Abortion ; VH Vertex-Heel length)
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9 Case 10
Previous pregnancy G1P1 G2P2 G3P2 G2P2 G2P2 G3P1 (2SA) G2P2 G6P1 (5SA) G6P1 (5SA) G4P2
Gestational Age (GW) 32 34 21 34 24 26 26 23 16 19
Karyotype 46,XX 46,XY 46,XY 46,XX 46,XX 46,XY 46,XY 46,XX 46,XY 46,XX
Fetal echocardiography           
     increased nuchal translucency
- - + (value ND) - - + (3,2mm for CRL of 49mm) ND ND
+ (5,2mm for 
CRL of 
57mm)
+ (3mm for 
CRL of 
58mm)
     IUGR + short limbs + + + + + ND - +
     oligo/anamnios - - + + - - ND + + -
     extremities anomalies -
postaxial 
polydactyly left 
hand
postaxial 
polydactyly - -
postaxial 
polydactyly of 
hands/irregular 
toes
polysyndactyly 
of feet - - hexadactyly?
     cardiopathy
pulmonary 
valvular 
dysplasia
AVC CIV? - AVC partial AVC AVC AVC
AVC, HLH, 
mitral 
hypoplasia
AVC
    microcephaly / brain anomalies microcephaly CCA partial CCA? microcephaly CC anomalies -
microcephaly/ 
gyration 
retardation
CCA - -
     others anomalies  
renal/lung 
anomalies, sexual 
ambiguity
 laparoschisis/ small kidneys
bilateral cleft 
lip and palate 
and renal 
anomalies
 retrognatism
bilateral 
renal 
agenesis
kidneys and 
bladder not 
seen
stomach and 
kidneys not 
seen
Weight(g) /CH(cm) / foot length(cm) 1128/37,5/5,6 625/31,5/4,3 250/21/3 1896/43/6,8 390/27,5/3,7 677/31/4,6 545/29,5/4,1 337/23/3 89/15/1,7 130/18,5/2
IUGR + 10-25th + 10-25th + + + + - +
Microcephaly (centiles) / brain weight + 5th / 87g 5th / 40g + / 212g 5th / 86,5g + / 91g 5th / ? + / 54g - / 26g + / 19,5g
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Facial dysmorphism           
bitemporal narrowing + - + + - - + + - -
hypertelorism + + + + - + + - + -
anteverted nares/upturned + + + + - + + + + +
microretrognathia + + + + - + + + + +
smooth/convex philtrum - + - +  + + + + +
short philtrum + - + +   + + - -
low-set/posteriorly rotated ears + + + + + + + - + +
short neck + + + + + + + + + +
large mouth - - + - + + + +  +
midline cleft palate/bifid uvula - cleft palate - bifid uvula bilateral CLP - - - - cleft palate
narrow palate + ND - -  + - - +  
Micromelia + + + + + + + + + +
Feet anomalies           
Syndactyly of toes II-III + + + + + + + + + +
short hallux + + - - + - - + - -
post-axial polydactyly (L,R or B) - - + L - - + B + R + R + B -
Hands anomalies           
post-axial polydactyly (L,R or B) - + L + B - - + B - + B + B -
short/proximally placed thumbs + + + + + - - - + +
extended distal palmar crease  + + + + ND - + - ND ND
External genitalia anomalies -
open urogenital 
groove and 
unfused genital 
swelling
bifid scrotum - - external female genitalia
open urogenital 
groove and 
unfused genital 
swelling
- + -
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Table 2: Visceral and radiological anomalies of the 10 fetuses with Smith-Lemli-Opitz syndrome
(AVCD Atrioventricular ; APVR Anomalous Pulmonary Venous Return ; CCA Agenesis of the corpus callosum ; HLH Hypoplastic Left Heart ; HPE 
Holoprosencephaly ; N Normal ; NA: not available ; VSD Ventricular Septal Defect)
 Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9 Case 10
Gonads ovaries testes testes ovaries ovaries testes testes ovaries testis ovaries
Kidney sigmoid kidney / hypoplasia
Left pelvicaliceal 
dilatation
hypo/aplasia + 
cysts hypoplasia hypoplasia hypoplasia hypoplasia Bilat agenesis
severe 
hypoplasia left pelvic kidney
Cardiovascular
pulmonary 
valvular 
dysplasia, short 
ductus 
arteriosus.
AVC  with riht 
ventricular 
hypoplasia
HLH, arch aortic 
tubular 
hypoplasia and 
subaortic VSD.
- Partial AVCD
Left cavities 
hypoplasia, 
partial AVCD 
and APVR
AVC AVC AVCD and mitral atresia AVC
Lung Lobation anomalies
lobation 
anomalies /cysts hypoplasia
lobation 
anomalies N
absent lobation / 
fused lungs
lobation 
anomalies / 
hypoplasia
absent lobation absent lobation lobation anomalies
CNS ? posterior CCA
hypothalamic 
and pallidum 
dysgenesis and 
cranial nerves 
ganglia lesions
microcephaly lobar HPE
cerebellar and 
brainstem 
abnormalities / 
Hypothalamic 
hamartoma
NK
CCA / rare 
neuronal 
heterotopia / 
holomyelia
- ACC
Gastrointestinal - intestinal malrotation
laparoschisis / 
common 
mesentery
-
Incomplete 
common 
mesentery
- - - -
Others enlarged caudal pancreas
bicornuate 
uterus bicolli
enlarged caudal 
pancreas polysplenia
polysplenia 
/single umbilical 
artery
single umbilical 
artery/ 
bicornuate uterus
Skeletal
   Short long bones + (F= 49 mm) + (F= 35 mm)
+ Right ulnar 
hypoplasia (F= 
NK)
-  (F=62 mm) + (F=36 mm) + (F= 35 mm) + (F= 36 mm) + (F= 29 mm) + (F= NK) + (F= NK)
   Brachymesophalangy of 2d finger(s) + + + + + NK NK + NK +
Placenta (weight)
hypotrophy 
(229g ; 5-10th ; 
325g=M 32)
N (235g ; 75-
90th) N (94g ; <10th)
N (417g ; 50-
75th)
hypotrophy 
(128g ; 10th ; 
190g=M 24)
N (240g ; 50-
75th)
hypotrophy 
(120g ; 5-10th ; 
226g=M 26)
155g N (69g ; 25-50th) N (97g ; 10-50th)
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Table 3: Biochemical and genetic data of the 10 fetuses with SLOS
Cases Tissus
Cholesterol 
(mg/g) 7-DHC (mg/g) 8-DHC (mg/g) 7+8DHC/Chol Mutations (1 line per allele)
1 Liver 0,76 0,34 0,53 1,14 c.356del13nt (p.His119ProFsX23)c.906C>G (p.Phe302Leu)
2 Fetal blood 113 mg/l 77mg/l 299mg/l 3,33 c.1228G>A (p.Gly410Ser)c.964-1 G>C (IVS8-1G>C)
3 Lung 0,22 1,57 1,91 15,82 c.438C>G (p.Asn146Lys)IVS8-1G>C 
4 Liver 1,6 0,05 0,08 0,08 c.506C>T (p.Ser169Leu)IVS8-1G>C 
5 Lung 0,41 1 0,99 4,85
c.149C>T (p.Ala50Val)
c.208G>T (p.Gly70Cys)
c.628A>T (p.Lys210X)
6 Liver 0,21 0,6 1,14 8,29 IVS8-1G>CIVS8-1G>C 
6' 
(miscarriage) Trophoblast 2,22 0,372 0,088 0,21  -
7 Liver 0,26 2,2 3,33 21,27 IVS8-1G>CIVS8-1G>C 
8 NA NA NA NA IVS8-1G>Cc.452G>A (p.Trp151X)
9 Liver 0,18 0,55 1,69 12,44 IVS8-1G>Cc.682C>T (p.Arg228Trp)
10 Liver 0,104 0,21 0,224 4,17 IVS8-1G>CIVS8-1G>C 
Normal (n=28) Liver 3.98±1.75 0.003±0.003 0.006±0.004 0.002±0.002
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Table 4: Phenotypic overlap of SLO and Pallister-Hall syndromes
PHS SLOS
Gene GLI3 DHCR7
Inheritance pattern Autosomal Dominant Autosomal Recessive 
IUGR +++ +
Renal Hypoplasia/agenesis hypoplasia
Lund segmentation defects + +
Cardiovascular defects rare +
Imperforate anus + rare
Hypothalamic hamartoma + rare
Epiglottic/laryngeal 
abnormalities
+ -
Extremities
Post-axial and central 
polydactyly, dysplastic nails, 
brachytelephalangism
Post-axial polydactyly and 2/3 
toe syndactyly
Genital 
Rare (hydrometrocolpos, 
vaginal atresia, urogenital 
sinus, cloaca)
+ (male)
Facial dysmorphism
Downward slanting palpebral 
fissures, short nose with 
anteverted nares
Bitemporal narrowing, 
anteverted nares
15
Legend to figures
Figure 1: Facial dysmorphism of fetuses 1 to 10
(A)  Profile pictures of fetuses 1 to 10 – (B) Frontal view of fetuses 1 to 8. Note bitemporal narrowing,  
hypertelorism, short nose with anteverted nares, microretrognathia (severe for case 3), full cheeks, 
large mouth, low set and posteriorly rotated ears and short neck (figure numbering refers to the case 
numbers).
Figure 2: Acral anomalies  in fetal SLOS
Note deep distal  palmar crease between second and third fingers which have sometimes widely 
spaced (“split hand like”) in cases 1, 2, 3, 4 and 7. Cases 2, 3, 6, 8 and 9 have postaxial hexadactyly.  
Case 8 has no palmar crease. Cases 8 and 10 have bilateral ulnar club hands. Thumbs are often short  
and  proximally  placed.  Note  some  fetuses  with  camptodactyly  and  fifth  finger  clinodactyly.  All  
fetuses except case 9 have bilateral syndactyly of toes II-III. Case 3 has syndactyly of toes II-III and IV-
V.  Cases  3,  6,  7,  8  and  9  have  unilateral  or  bilateral  post-axial  hexadactyly.  Case  8  has  fibular 
deviation of toes. Hallux are sometimes short and broad.
Figure 3: Abnormal external genitalia in SLOS
Cases 1 and 5 are female with normal external genitalia. Cases 2 and 7 have ambiguous genitalia with 
small  genital  tubercle,  open urogenital  groove and unfused genital  swelling.  Case 3 has  bifid  or  
incomplete fused scrotum. Case 6 is 46,XY with phenotypically female appearance.
Figure 4A: Unusual malformations in SLOS
(a):  congenital pulmonary adenomatoid malformation within the left  upper lobe in fetus 2 -  (b):  
absent pulmonary lobulation with posterior fused lungs  in fetus 6 - (c,d): bicornuate uterus bicollis -  
(e): laparoschisis .
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Figure 4B: CNS unusual malformations in SLOS
(a,b): hypothalamic hamartoma (arrow) in fetus 6 - (c): anterior spinal cord fusion (holomyelia) in 
fetus 8 (arrow).
Figure 5: Radiographic highlights in SLOS
(A): brachymesophanlangy of second finger in seven fetus - (B): associated right ulnar hypoplasia in 
case 3 - (C): vertebral segmentation defects (hemivertebra, agenesis of last sacral vertebra) in case 3.
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